Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-09-03$39.49/sh−550$21,720→ 38,333 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 08/30/2024.